Mymetics Acquires Malaria Vaccine From Pevion
Posted on: Tuesday, 20 May 2008, 09:01 CDT
Mymetics, a vaccine development company, has acquired a preventive malaria vaccine from Switzerland-based Pevion Biotech.
The Pevion vaccine has successfully completed human clinical trial Phases I and II in Switzerland and in the UK, respectively, with only two of four contemplated antigens. The clinical trials are being conducted in connection with the application for approval of this vaccine under the EU regulations.
A Phase Ib clinical trial has been launched in Tanzania to extend the protocol to children and teenagers in a naturally endemic area. A new cycle of Phase I and II clinical trials with all four antigens is scheduled thereafter.
Christian Rochet, CEO and president of Mymetics, said: "We are pleased with this acquisition which allows us to start feeding a pipeline of products for the future, in addition to our preventive HIV/AIDS vaccine."
Source: Datamonitor
Related Articles
- Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5
- Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties
- Location Change for Department of Health's H1N1 Vaccine Clinic in Delaware County
- Macomb County Health Department Schedules Communitywide H1N1 Flu Vaccine Clinic Nov. 24
- Macomb County Health Department Schedules Two New H1N1 Flu Vaccine Clinics Nov. 17 and 19; One Each Targeting Pregnant Women and Health Care Workers
- Ichor Melanoma Vaccine Clinical Trial Moves to Highest Dose Level
- Montefiore Medical Center Launches HPV Vaccine Clinic
- Are You Rabies-Ready?: Unifour Counties Planning Inexpensive Vaccination Clinics for Pets
- MD-Based Maxim Health Cancels All Flu Vaccine Clinics
- South County Hospital Holds Flu Vaccination Clinics
 |
 |
User Comments (1)
| 1. |
Posted by alix on 05/21/2008, 13:58 that sucks |
RSS Feeds